Artificial synthesis of the type III secretion system translocon. A new approach to vaccine design [ 2017 - ]

Research Grant

Researchers: Dr Lawrence Lee (Principal investigator) ,  A/Pr Richard Berry ,  Prof Andrew Turberfield ,  Prof Keiichi Namba

Brief description Today hospitals are plagued with bacterial infections that do not respond to antibiotics. The problem exists because although antibiotics are effective at killing bacteria, this paradoxically also helps the drug-resistant bacteria thrive. We will pioneer a completely new approach to vaccine design that allows us to construct a vaccine that protects us from bacterial infection without killing the bacteria. The vaccine should therefore be far less susceptible to drug resistance.

Funding Amount $668,742.00

Funding Scheme Project Grants

Notes Standard Project Grant